These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 6261051

  • 1. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E, Wolf H, Deinhardt F, Naumann HH.
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [Abstract] [Full Text] [Related]

  • 2. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981 Jan; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 5. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Feb; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A, Corradini C, Venanzoni M, Cardi G, Bevere F, Barile G, Zompetta C, Frati L.
    J Exp Pathol; 1987 May; 3(4):471-7. PubMed ID: 2842480
    [Abstract] [Full Text] [Related]

  • 11. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 12. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 13. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH, Soo MY, Gan YY, Fones-Tan A, Sim PS, Kaur A, Chew CT.
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [Abstract] [Full Text] [Related]

  • 14. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
    Pavelka R, Popow-Kraupp T, Radaszkiewicz T.
    Wien Klin Wochenschr; 1985 Jul 19; 97(14):588-95. PubMed ID: 2996246
    [Abstract] [Full Text] [Related]

  • 15. [Tonsillar cancer and Epstein-Barr virus].
    Wilmes E, Wolf H, Haus M.
    Laryngol Rhinol Otol (Stuttg); 1983 Dec 19; 62(12):586-9. PubMed ID: 6323895
    [Abstract] [Full Text] [Related]

  • 16. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC.
    Bull Cancer Radiother; 1996 Dec 19; 83(1):3-7. PubMed ID: 8679277
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA.
    Head Neck; 2004 Jul 19; 26(7):598-602. PubMed ID: 15229902
    [Abstract] [Full Text] [Related]

  • 18. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 19. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992 May 20; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 20. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R, Gurtsevich V, Le Riverend E.
    Neoplasma; 1979 May 20; 26(2):125-31. PubMed ID: 224330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.